Trial Profile
Experience of High Adherence Rate of Mirabegron in Patients with Overactive Bladder in Japan: Comparison Between Gender, and Between Single and Combined Pharmacotherapies
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Sep 2018
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 31 Aug 2018 Results presented at the 48th Annual Meeting of the International Continence Society
- 05 Nov 2015 New trial record
- 09 Oct 2015 Results presented at the 45th Annual Meeting of the International Continence Society